Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has informed the exchanges about an earnings call scheduled for Monday, May 26, 2025, from 8:30 a.m. to 9:30 a.m. IST to discuss its Q4 FY2024-25 results. The call will have dial-in numbers for participants in India, USA, UK, Singapore, and Hong Kong, along with a pre-registration link. A recording of the call will be made available on the company's website within 24 hours of the call. This is a routine disclosure informing investors and analysts about the upcoming results discussion.
No direct impact on shareholders — this is a procedural announcement. Investors and analysts should watch the Q4 FY25 results and management commentary on the call for insights into business performance and outlook.